トピック 4
3月26日［金］18:00-19:00
|
| |
| |
Forefront of treatment for cardiac amyloidosis
|
|
|
| |
| |
|
|
| |
ATTRACT試験、四量体安定化剤上市、PYPシンチの適応追加などを契機に心アミロイドーシスの早期診断、治療が注目を集めている。豊富な診療経験を有する演者陣とともに最新の治療と今後の展望について議論する。
|
|
|
| |
| |
|
|
| |
| |
 |
|
Hiroaki Kitaoka
Department of Cardiology and Geriatrics, Kochi Medical School, Kochi
|
|
 |
|
Kenichi Tsujita
Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto
|
|
|
| |
| |
|
|
| |
| |
 |
|
Claudio Rapezzi
University of Ferrara, Italy/Maria Cecilia Hospital, GVM Research and Care, Cotignola, Italy
|
|
 |
|
Yoshiki Sekijima
Department of Neurology & Rheumatology, Shinshu University School of Medicine,Matsumoto
|
|
|
| |
| |
 |
|
Nobuhiro Tsukada
Department of Hematology, Japanese Red Cross Medical Center, Tokyo
|
|
 |
|
Jin Endo
Department of Cardiology, Keio University School of Medicine, Tokyo
|
|
|
| |
| |
|
|